Agneta Edberg has over 20 years experience from leading positions in life science. Edberg’s previous positions include Managing director and Vice President of Mylan AB, the Nordic countries, CEO for LFF Service AB, the Swedish Pharmaceutical Insurance Association and NM Pharma AB and senior positions from LinkMed AB (Allenex), Pfizer, Pharmacia, Bactiguard and Cilag (Johnson & Johnson) AB. Her previous board assignments include chairman of Immunicum AB (publ), Health Solutions AB, BioResonator Good Eye AB and BioMatCell – Vinn Excellence Center of Biomaterials and Cell Therapy. Current assignments include Chairman at Likvor AB and Ambulanssjukvården i Storstockholm AB (AISAB), board member of TSS AB, CAMP (a Swedish Consortium Center for Advanced Medical Products) and member of CellProtect AB. Agneta Edberg has a degree in health economics from Stockholm School of Economics as well as a biomedical education from Sundsvall University.
Holdings: 54,965 shares
Independent in relation to the Company and its management and the Company´s major shareholders.